Correlation Between Citigroup and Algos Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Algos Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Algos Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Algos Pharmaceutical Corp, you can compare the effects of market volatilities on Citigroup and Algos Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Algos Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Algos Pharmaceutical.

Diversification Opportunities for Citigroup and Algos Pharmaceutical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Citigroup and Algos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Algos Pharmaceutical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algos Pharmaceutical Corp and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Algos Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algos Pharmaceutical Corp has no effect on the direction of Citigroup i.e., Citigroup and Algos Pharmaceutical go up and down completely randomly.

Pair Corralation between Citigroup and Algos Pharmaceutical

If you would invest  4,237  in Citigroup on September 4, 2024 and sell it today you would earn a total of  2,902  from holding Citigroup or generate 68.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Citigroup  vs.  Algos Pharmaceutical Corp

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Algos Pharmaceutical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Algos Pharmaceutical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Algos Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Citigroup and Algos Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Algos Pharmaceutical

The main advantage of trading using opposite Citigroup and Algos Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Algos Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algos Pharmaceutical will offset losses from the drop in Algos Pharmaceutical's long position.
The idea behind Citigroup and Algos Pharmaceutical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios